Can the Future be Bright with Advances in Diabetic Eye Care?

The prevalence of diabetic retinopathy is steadily increasing as the population of patients with diabetes grows. In the past decade, the development of anti-VEGF agents has dramatically changed the treatment landscape for diabetic retinopathy and diabetic macular edema (DME). Newer agents in development aim to reduce the treatment burden of diabetic retinopathy

Source: Endocrinology and Metabolism Clinics of North America - November 17, 2022 Category: Endocrinology Authors: Samantha Paul, Christian Kim, Mohamed Kamel Soliman, Warren Sobol, Jose J. Echegaray, Shree Kurup Source Type: research